# Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

> clinical trial · VERIFIED · 2026-07-15

Status: RECRUITING · Sponsor: M.D. Anderson Cancer Center · Condition: Advanced Malignant Solid Neoplasm

- Company: M.D. Anderson Cancer Center
- Sector: Advanced Malignant Solid Neoplasm
- Primary source: https://clinicaltrials.gov/study/NCT05039632

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.